BIOGERONTOLOGY, published by SPRINGER, is a premier journal dedicated to the interdisciplinary study of biological aging processes and their implications for health and longevity. With an ISSN of 1389-5729 and an E-ISSN of 1573-6768, this journal features cutting-edge research that addresses critical questions in the fields of aging, geriatrics, and gerontology. Ranking impressively in the top quartiles, particularly as Q1 in Gerontology, BIOGERONTOLOGY is recognized for its contributions to advancing the understanding of aging at both molecular and systemic levels. The journal’s rich repository of scholarly articles provides valuable insights for researchers, healthcare professionals, and students alike, fostering a deeper comprehension of age-related biological mechanisms. Although not an open-access journal, it is highly regarded with an impact factor that reflects its significant role in the academic community. The journal spans from 2000 to 2024, ensuring a broad historical context for its studies, and is based in the Netherlands, with its administrative office located at One New York Plaza, Suite 4600, New York, NY 10004, United States. Engaging with BIOGERONTOLOGY means joining a global dialogue on the science of aging and the implications it holds for humanity.

Clinical Epigenetics is a pioneering open-access journal published by BMC, dedicated to advancing the field of epigenetics and its critical implications in clinical and translational research. Established in 2011, the journal has become an authoritative resource in the realms of developmental biology, genetics, and molecular biology, as evidenced by its impressive 2023 Scopus categorization as a Q1 journal in multiple domains including clinical genetics. With a robust impact factor and rankings that place it among the top quartiles in its fields—Rank #13 in Clinical Genetics and #14 in Developmental Biology—Clinical Epigenetics serves as an essential platform for researchers, professionals, and students alike, encouraging the dissemination of high-quality research findings. Operating from its United Kingdom headquarters, this journal not only contributes to scholarly dialogue across the globe but also supports unrestricted access to vital findings that push the boundaries of our understanding of epigenetic mechanisms and their clinical applications.

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, published by Wiley, stands at the forefront of research dedicated to the intricate relationship between genetics and neuropsychiatric disorders. With an impressive scope that bridges various disciplines, this journal serves as a premier platform for groundbreaking studies and innovative perspectives in the fields of Cellular and Molecular Neuroscience, Genetics, and Psychiatry and Mental Health. Featuring a robust impact factor and categorized in the Q1 and Q2 quartiles across multiple relevant categories, the journal has successfully positioned itself as a leading source of high-quality research, ranking 52nd in Cellular and Molecular Neuroscience, 37th in Clinical Genetics, and 157th in Psychiatry and Mental Health within Scopus. Since its inception in 1995, it has sustained a commitment to fostering scholarly excellence and advancing our understanding of the genetic underpinnings of mental health. The journal is poised to continue its mission until 2024 and offers open access options, facilitating wider dissemination of vital knowledge among researchers, healthcare professionals, and students alike.

RNA is a premier journal in the field of molecular biology, published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT. With an impressive impact factor reflected by its Q1 status in the Molecular Biology category, this journal has established itself as an essential resource for researchers and professionals dedicated to understanding the role of RNA in biological processes. Spanning over two decades of impactful research from 1995 to 2024, RNA covers a broad spectrum of topics, including RNA biology, gene regulation, and therapeutic innovations. Researchers can access its extensive array of original research articles, reviews, and commentary, making it a vital conduit for new discoveries and methodologies in the field. With its high ranking within Scopus at Rank #115/410 and a 72nd percentile ranking in the domain of Biochemistry, Genetics, and Molecular Biology, RNA continues to advance the understanding of RNA and its critical contributions to life sciences.

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.

Environmental Epigenetics, published by Oxford University Press, is a leading open access journal dedicated to advancing the understanding of the epigenetic mechanisms that underpin environmental influences on health and disease. With an ISSN of 2058-5888 and established as an open access platform since 2015, this journal serves as a vital resource for researchers in the fields of genetics, environmental science, and health, offering insights from multidisciplinary perspectives. The journal has gained notable recognition in the academic community, reflected by its impressive Scopus rankings and its classification in the second quartile (Q2) for Genetics and other related disciplines as of 2023. It aims to foster innovative research that bridges laboratory findings and real-world environmental issues, making it an indispensable tool for professionals and students pursuing knowledge at the intersection of genetics, environmental science, and public health. With its commitment to disseminating valuable research findings freely, Environmental Epigenetics stands out as an essential publication for those aiming to understand the significant impacts of environmental factors on genetic expression.

NAR Cancer, published by Oxford University Press, is a pioneering open access journal established to advance the rapidly evolving field of cancer research. Since its inception in 2019, this journal has gained substantial recognition, achieving a prestigious Q1 ranking in both Cancer Research and Oncology categories as of 2023. With a focused objective to disseminate high-quality research, reviews, and insights into innovative cancer treatments and diagnostics, NAR Cancer serves as an essential platform for researchers, healthcare professionals, and students alike. The journal is accessible for all since it became open access in 2020, ensuring a global reach and impact. Positioned in the competitive landscape of oncology, with impressive Scopus rankings, it offers a unique opportunity for contributors to share their work with an engaged and interdisciplinary audience. With a commitment to excellence, NAR Cancer is dedicated to driving forward the understanding and management of cancer worldwide.

CURRENT GENOMICS is a premier journal published by Bentham Science Publishers that focuses on the expansive field of genomics, including both clinical and molecular genetics. With the ISSN 1389-2029 and E-ISSN 1875-5488, this esteemed journal has been disseminating significant scientific insights since its inception in 2000 and continues to contribute to the field through 2024. Based in the United Arab Emirates, CURRENT GENOMICS boasts a Q3 ranking in both the genetics and clinical genetics categories for 2023, reflecting its growing impact in the scientific community. Although not an open-access journal, it provides valuable content that supports researchers and professionals in navigating the complexities of genetic research and its applications. By publishing original research articles, reviews, and case studies, CURRENT GENOMICS aims to foster a deeper understanding of genomic science and its implications for medicine, thus playing a critical role in the advancement of genetics and biomedical research.

TRENDS IN GENETICS, published by CELL PRESS, is a leading journal in the field of genetics, recognized for its significant impact on research and advancements in the discipline. With an impressive Scopus ranking of #10 out of 347 in the category of Genetics and a 97th percentile ranking, this journal stands as a premier platform for publishing innovative, high-quality articles that shape the future of genetic research. Since its inception in 1985, TRENDS IN GENETICS has been at the forefront of the genetic sciences, continuously disseminating crucial findings while maintaining a strong commitment to scientific rigor and integrity. Although it does not currently offer open access options, its rigorous peer-review process ensures that only the most relevant and groundbreaking studies make it to publication. Scholars and practitioners in genetics will find this journal to be an invaluable resource for keeping abreast of the latest developments, trends, and methodologies that drive the field forward.

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, published by BEGELL HOUSE INC, serves as a vital resource within the fields of Genetics and Molecular Biology. With the ISSN 1045-4403 and E-ISSN 2162-6502, this journal has been contributing to scientific discourse since 1990 and is projected to continue its publication until 2024. Despite its classification in the Q3 quartile for both Genetics and Molecular Biology, its impact on the research community is significant, as evidenced by its diverse range of critical reviews that synthesize and analyze emerging trends and foundational studies in gene expression. The journal, located in the United States at 50 North St, Danbury, CT 06810, offers a platform for researchers, professionals, and students to engage with innovative ideas and methodologies that drive forward the understanding of gene regulatory mechanisms in eukaryotes. Although it currently does not offer open access, the journal's content remains crucial for those dedicated to advancing knowledge in the intricacies of genetic expression.